Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
VALTES HOLDINGS, 3% Increase in Ordinary Profit for The Current Fiscal Year
4442 VALTES HOLDINGS CO.,LTD. 【J-GAAP】
Earnings ReportVALTES HOLDINGS CO.,LTD. <4442> [TSE Growth] announced its financial results after the market closed on May 14th (15:30). The consolidated ordinary profit for the fiscal year ended March 2026 decreased by 1.0% from the previous period to 921 million yen. For the fiscal year ending March 2027, the consolidated ordinary profit is expected to grow by 3.1% to 950 million yen. This will be the thirteenth consecutive term of revenue growth.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit decreased to 375 million yen, a 3.6% decrease compared to the same period last year. The operating profit margin decreased from 13.2% in the same period last year to 11.6%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 10,362 | 838 | 848 | 516 | 25.3 | 4 | May 14, 2024 | J-GAAP |
| Mar, 2025 | 10,795 | 927 | 930 | 580 | 28.8 | 4 | May 14, 2025 | J-GAAP |
| Mar, 2026 | 11,939 | 923 | 921 | 573 | 28.9 | 4 | May 14, 2026 | J-GAAP |
| YoY | +10.6% | -0.4% | -1.0% | -1.2% | +0.3% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2026 Guidance | 11,900 | 900 | 900 | 500 | 25.2 | 4 | Apr 23, 2026 | J-GAAP |
| Mar, 2026 Results | 11,939 | 923 | 921 | 573 | 28.9 | 4 | May 14, 2026 | J-GAAP |
| Revision Rate | +0.3% | +2.6% | +2.3% | +14.6% | +14.7% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2025 | 5,641 | 269 | 263 | 141 | 7.1 | 0 | Nov 14, 2025 | J-GAAP |
| Apr - Sep, 2026 Guidance | ー | ー | ー | ー | - | 0 | May 14, 2026 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2025 | 10,795 | 927 | 930 | 580 | 28.8 | 4 | May 14, 2025 | J-GAAP |
| Mar, 2026 | 11,939 | 923 | 921 | 573 | 28.9 | 4 | May 14, 2026 | J-GAAP |
| Mar, 2027 Guidance | 14,160 | 970 | 950 | 610 | 30.8 | 4 | May 14, 2026 | J-GAAP |
| YoY | +18.6% | +5.1% | +3.1% | +6.5% | +6.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2025 | 2,919 | 386 | 389 | 239 | 11.9 | 13.2 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,748 | 99 | 96 | 53 | 2.7 | 3.6 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,893 | 170 | 167 | 88 | 4.4 | 5.9 | Nov 14, 2025 | J-GAAP |
| Oct - Dec, 2025 | 3,064 | 279 | 283 | 192 | 9.7 | 9.1 | Feb 13, 2026 | J-GAAP |
| Jan - Mar, 2026 | 3,234 | 375 | 375 | 240 | 12.1 | 11.6 | May 14, 2026 | J-GAAP |
| YoY | +10.8% | -2.8% | -3.6% | +0.4% | +2.0% |
Related Articles
PRONEXUS, 5% Decrease in Net Income for The Current Fiscal Year, Increased Previous Year's Dividend by 4 Yen, This Fiscal Year to Increase Dividend by 2 Yen
Kurita Water Industries, 2.6 times Increase in Net Income, Record High for The First Time in Three Years, Dividend Raised by 22 Yen
AnyMind Group, Jan-Mar (1Q) Net Income Increases by 5.1 times
KADOKAWA, 3% Increase in Ordinary Profit for The Current Fiscal Year
Trial Holdings, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 24%
DLE, Returning to Profitability This Year
Noile-Immune Biotech, Jan-Mar (1Q) Ordinary Profit Loss Narrows
SYNCLAYER, Jan-Mar (1Q) Ordinary Profit Decreases by 26%
SERENDIP HOLDINGS, 36% Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term
Kamigumi, 8% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 20 Yen, Plan to Continue the 205 Yen Policy This Fiscal Year as Well